Hamden, CT, United States of America

Jinshan Chen

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Jinshan Chen: Innovator in Pharmaceutical Sciences**

Introduction

Jinshan Chen is a notable inventor based in Hamden, CT, whose contributions to the field of pharmaceutical sciences have garnered attention through his innovative work and multiple patents. With a total of four patents to his name, Chen's inventions are critical in advancing therapeutic options for various medical conditions.

Latest Patents

Among Jinshan Chen's latest inventions are two significant patents. The first, titled "Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agents," revolves around a novel class of compounds, specifically 2-arylimino heterocycles. These include 2-arylimino-1,3-thiazolidines and related structures, demonstrating potential in modulating progesterone receptor-mediated processes, thus serving as valuable pharmaceutical compositions in therapies.

His second recent patent, "Inhibition of p38 kinase activity by aryl ureas," details a method utilizing a specific group of aryl ureas for the treatment of cytokine-mediated diseases outside of cancer, as well as proteolytic enzyme-mediated conditions. This invention holds promise for developing new therapeutic strategies through unique pharmaceutical compositions aimed at such diseases.

Career Highlights

Jinshan Chen has established a successful career at Bayer Corporation, where he continues to innovate and push the boundaries of pharmaceutical research. His work contributes significantly to the company's portfolio of therapeutic solutions, further enhancing Bayer's reputation in drug development.

Collaborations

Throughout his career, Jinshan Chen has collaborated with other distinguished professionals, including coworkers Brian R. Dixon and William Johnston Scott. These collaborations have been pivotal in refining his inventions and propelling advancements in their respective fields.

Conclusion

In conclusion, Jinshan Chen exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only showcase his expertise in developing novel therapeutic agents but also pave the way for future breakthroughs in healthcare. As he continues to work with Bayer Corporation, the impact of his contributions is likely to resonate for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…